Duoduo Wu, Kai En Chan, Blanche Xiao Hong Lim, Dawn Ka-Ann Lim, Wendy Meihua Wong, Charmaine Chai, Ray Manotosh, Chris Hong Long Lim
Corneal neovascularization (CoNV) is a sight-threatening condition affecting an estimated 1.4 million people per year, and the incidence is expected to rise. It is a complication of corneal pathological diseases such as infective keratitis, chemical burn, corneal limbal stem cell deficiency, mechanical trauma, and immunological rejection after keratoplasties. CoNV occurs due to a disequilibrium in proangiogenic and antiangiogenic mediators, involving a complex system of molecular interactions. Treatment of CoNV is challenging, and no therapy thus far has been curative...
May 1, 2024: Indian Journal of Ophthalmology